Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results
Globe Newswire (Thu, 11-Dec 4:01 PM ET)
Market Chameleon (Wed, 3-Dec 5:34 AM ET)
KMTS to Reveal Q2 Fiscal 2026 Results: Key Dates and What Investors Should Watch
Market Chameleon (Wed, 3-Dec 3:59 AM ET)
Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results
Globe Newswire (Wed, 3-Dec 8:00 AM ET)
Globe Newswire (Tue, 2-Dec 10:11 PM ET)
Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares
Globe Newswire (Mon, 1-Dec 7:16 AM ET)
Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results
Globe Newswire (Mon, 1-Dec 7:01 AM ET)
Globe Newswire (Mon, 10-Nov 9:52 AM ET)
Globe Newswire (Tue, 4-Nov 8:00 AM ET)
Kestra Medical Technologies to Present at the Stifel 2025 Healthcare Conference
Globe Newswire (Tue, 28-Oct 8:00 AM ET)
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Kestra Medical Techs trades on the NASDAQ stock market under the symbol KMTS.
As of December 19, 2025, KMTS stock price climbed to $27.32 with 794,484 million shares trading.
KMTS has a beta of 1.07, meaning it tends to be more sensitive to market movements. KMTS has a correlation of 0.08 to the broad based SPY ETF.
KMTS has a market cap of $1.59 billion. This is considered a Small Cap stock.
Last quarter Kestra Medical Techs reported $23 million in Revenue and -$.64 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.07.
The top ETF exchange traded funds that KMTS belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
KMTS support price is $25.63 and resistance is $28.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMTS shares will trade within this expected range on the day.
